Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Figure 3

Deterministic sensitivity analysis: impact of vaccinating boys and girls versus girls only vaccination when considering the reduction of remaining burden of female and male carcinomas cases and percentage of relative variation versus base case analysis ‡. GNV, gender-neutral vaccination (boys and girls vaccination). †: same coverage rate and duration of protection are assumed to be applied to boys and girls vaccination and girls only vaccination. ‡: boys and girls vaccination (cumulative vaccination coverage rate 70%, lifetime duration of protection).

Back to article page